$17.32
0.633.77%
al cierre: Aug 19, 5:00 PM EST
$17.32
N/A
After hour: 4:00 PM EST
Crescent Biopharma (CBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.67 | $-0.80 | $-2.58 | $-1.23 |
| Actual | $-0.74 | $-0.70 | $-4.01 | $-1.27 |
| Surprise | -10.4% | +12.5% | -55.4% | -3.25% |
| Revenue | ||||
| Estimate | $357140 | $357140 | $12.5M | — |
| Actual | $0 | $1.0M | $10.8M | $0 |
| Surprise | -100.0% | +190.9% | -13.3% | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.60 | $-0.63 | $-0.84 | $-0.89 |
| Revenue | ||||
| Consensus | $357140 | $357140 | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $-0.74 | $-0.67 | -10.4 % |
| Q1 | Apr 29, 2026 | $-0.70 | $-0.80 | 12.5 % |
| Q4 | Feb 26, 2026 | $-4.01 | $-2.58 | -55.4 % |
| Q3 | Nov 6, 2025 | $-1.27 | $-1.23 | -3.25 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $0 | $357.14K | -100.0 % |
| Q1 | Apr 29, 2026 | $1.04M | $357.14K | 190.9 % |
| Q4 | Feb 26, 2026 | $10.84M | $12.50M | -13.3 % |